2010 |
Binding Site Wins Queen's Award for International Trade |
 |
Binding Site has been named a winner of The Queen's Award for Enterprise 2010 in the International Trade category.
The award has been granted in recognition for outstanding achievement in increasing export revenues by 74% to over £42 million/year in 3 years and selling more than 90% of its production overseas. Aggregate exports over this period totalled £96 million. |
2007 |
Binding Site Wins Queen's Award for Innovative Cancer Marker |
 |
Binding Site has been named a winner of The Queen's Award for Enterprise 2007 in the Innovation category. The award has been granted in recognition of the development of Freelite®, a novel diagnostic assay for the diagnosis and monitoring of multiple myeloma, a type of Bone Marrow cancer. Launched in 2000 the Freelite® assay is used in hospital laboratories worldwide to help diagnose Multiple Myeloma and to monitor the effectiveness of treatment in patients receiving chemotherapy. Previously used laboratory diagnostic techniques were not always as sensitive as the Freelite assay which allows doctors to use a simple blood test to monitor their patients. In rare forms of the disease, monitoring with Freelite is the only way to assess whether a patient is responding to therapy or whether the therapy needs to be changed to better treat the patient. In this group of patients the Freelite assay has revolutionized the way doctors can select the appropriate treatment for each individual patient. |
